Milestone Pharmaceuticals Inc banner

Milestone Pharmaceuticals Inc
NASDAQ:MIST

Watchlist Manager
Milestone Pharmaceuticals Inc Logo
Milestone Pharmaceuticals Inc
NASDAQ:MIST
Watchlist
Price: 1.7 USD -2.86% Market Closed
Market Cap: $144.8m

Intrinsic Value

The intrinsic value of one MIST stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.7 USD, Milestone Pharmaceuticals Inc is hidden .

MIST Intrinsic Value
HIDDEN
Show

Valuation History
Milestone Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

MIST looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether MIST usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about MIST?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MIST valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Milestone Pharmaceuticals Inc.

Explain Valuation
Alternatives to MIST

Wall St
Price Targets

Dividends

Milestone Pharmaceuticals Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

MIST Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MIST stock?

The intrinsic value of one MIST stock under the Base Case scenario is hidden USD.

Is MIST stock undervalued or overvalued?

Compared to the current market price of 1.7 USD, Milestone Pharmaceuticals Inc is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett